AML
Photo of Matteo Molica from LinkedIn

Therapeutic time window from diagnosis to treatment for elderly AML patients

Matteo Molica, Hematologist Medical Director at UOC Hematology Oncohaematology Department at the Apulian Ciaccio Hospital, shared on LinkedIn:

““Is there a better therapeutic time window from diagnosis to treatment for elderly acute myeloid leukemia (AML) patients receiving hypomethylating agents?”

New paper on acute myeloid leukemia. Thanks to all colleagues.”

Source: Matteo Molica/LinkedIn